Neuca

Neuca Pre-Tax Margin

The Pre-Tax Profit Margin of Neuca (NEU.WA) as of Oct 21, 2026 is 1.50 %. In the previous year, Pre-Tax Profit Margin was 1.80 % — a change of -16.57% (lower).

Pre-Tax Margin

1.50 %

YoY

-16.57%

Last updated:

Pre-Tax Profit Margin of Neuca is 2025 1.50 % . Pre-Tax Profit Margin of Neuca was 2024 1.80 % . It decreases by -16.57% lower compared to the previous year.

The Neuca Pre-Tax Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pre-Tax Margin
Date
Pre-Tax Margin
Jan 1, 2018
1.67 PLN
Jan 1, 2019
1.87 PLN
Jan 1, 2020
2.10 PLN
Jan 1, 2021
2.05 PLN
Jan 1, 2022
1.80 PLN
Jan 1, 2023
1.73 PLN
Jan 1, 2024
1.80 PLN
Jan 1, 2025
1.50 PLN
The Neuca Pre-Tax Margin history
YEARPre-Tax MarginYoY
1.50 %-16.57%
1.80 %+4.33%
1.73 %-4.05%
1.80 %-12.30%
2.05 %-2.22%
2.10 %+11.97%
1.87 %+12.00%
1.67 %+1.15%
1.65 %-16.55%
1.98 %+13.54%
1.74 %+45.64%
1.20 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neuca Stock analysis

What does Neuca do? NEUCA SA generates revenue through the wholesale distribution of pharmaceutical products to pharmacies, leveraging its extensive network in the health market. The company also produces and sells its own branded drugs, supplements, and cosmetics, while offering clinical trials, telemedicine services, and IT solutions tailored for healthcare providers. Its e-commerce platform further supports the healthcare industry by enabling digital transactions for medical products and services. The primary buyers include pharmacies, healthcare institutions, and consumers seeking health-related products through online channels. NEUCA SA's business model integrates multiple revenue streams within the health sector, with a focus on both physical and digital distribution. The firm's own-brand products, such as pharmaceuticals and cosmetics, are sold directly to end-users and retail partners, while its IT solutions and telemedicine services target healthcare organizations. Clinical trials represent another key segment, attracting partnerships with research institutions and pharmaceutical firms. The company's operational scope spans from production to distribution, ensuring a comprehensive approach to healthcare market needs. The company's revenue is driven by its diversified portfolio, including drug distribution, branded product sales, and specialized services like telemedicine and clinical trials. Pharmacies remain the core customer segment for its wholesale operations, while e-commerce and IT solutions cater to a broader audience of healthcare providers and consumers. NEUCA SA's strategic positioning in the health market allows it to capitalize on multiple growth areas without relying on a single revenue source. Neuca is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neuca stock

Pre-Tax Profit Margin of Neuca is 1.50 % in 2025.

Pre-Tax Profit Margin of Neuca changed from 1.80 % to 1.50 %, representing a -16.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin Neuca since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's Neuca with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Neuca

All Key Metrics — Neuca